Both in Pharmaceuticals
Celularity vs NextCure
Over the past year CELU returned −53.0% and NXTC returned −38.7%; their daily moves had a correlation of 0.08.
CELU −53.0% NXTC −38.7%Growth of $1, one year, split-adjusted
| Metric | CELU | NXTC |
|---|---|---|
| Price | $0.9401 | $6.34 |
| Market cap | $30.5M | $29.0M |
| Today | +18.97% | +10.94% |
| 1 month | −31.4% | +30.9% |
| 6 months | −2.1% | −29.1% |
| Year to date | −15.3% | −55.3% |
| 1 year | −55.0% | −31.6% |
| Revenue growth (YoY) | −5.3% | — |
| Gross margin | 56.8% | — |
| Net margin | 10.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.6× | — |
| Net cash | -$37.1M | $20.1M |
| Dividend yield | — | — |
| Volatility (60d) | 222.5% | 115.9% |
| Short % of float | 6.7% | 8.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).